Beneficial 2-years results of drug-eluting stents in saphenous vein graft lesions

EuroIntervention

Volumn 4, Issue 1, 2008, Pages 108-114

  Assali, Abid ^a   Raz, Yael ^a   Vaknin Assa, Hana ^a   Ben Dor, Itsik ^a   Brosh, David ^a   Teplitsky, Igal ^a   Fuchs, Shmuel ^a   Kornowski, Ran ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Drug eluted stent; Restenosis; Saphenous vein grafts

Indexed keywords

RAPAMYCIN; METAL;

AGED; ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR ADVERSE CARDIAC EVENT; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; STENT THROMBOSIS; TARGET LESION REVASCULARISATION; TARGET VESSEL REVASCULARISATION; VEIN GRAFT DISEASE; ANGIOCARDIOGRAPHY; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; GRAFT OCCLUSION; MIDDLE AGED; MORTALITY; RADIOGRAPHY; RESTENOSIS; RETROSPECTIVE STUDY; SAPHENOUS VEIN; STATISTICAL MODEL; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY; TRANSPLANTATION; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; HUMANS; LOGISTIC MODELS; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; SAPHENOUS VEIN; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 59249097377     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV4I1A18     Document Type: Article

References (25)

1. Weintraub WS, Jones EL, Morris DC, King SB 3rd, Guyton RA, Craver JM. Outcome of reoperative coronary bypass surgery versus coronary angioplasty after previous bypass surgery. Circulation 1997;95: 868-877.
2. Salomon NW, Page US, Bigelow JC, Krause AH, Okies JE, Metzdorff MT. Reoperative coronary surgery: Comparative analysis of 6591 patients undergoing primary bypass and 508 patients undergoing reoperative coronary artery bypass. J Thorac Cardiovasc Surg 1990;100: 250-259.
3. Savage MP, Douglas JS Jr, Fischman DL, Pepine CJ, King SB 3rd, Werner JA, Bailey SR, Overlie PA, Fenton SH, Brinker JA, Leon MB, Goldberg S. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med 1997;337: 740-747.
4. Hanekamp CE, Koolen JJ, Den Heijer P, Schalij MJ, Piek JJ, Bar FW, De Scheerder I, Bonnier HJ, Pijls NH; Venestent Study Group. Randomized study to compare balloon angioplasty and elective stent implantation in venous bypass grafts: The VENESTENT study. Catheter Cardiovasc Interv 2003;60: 452-457.
5. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE; SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349: 1315-1323.
6. Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME; TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350: 221-231.
7. Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, Schuhlen H, Schmitt C, Dirschinger J, Schomig A; ISAR-DESIRE Study Investigators. Sirolimus-eluting stent or paclitaxel-eluting stent vs. balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis. A randomized controlled trial. JAMA 2005;293: 165-171.
8. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R; RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization, N Engl J Med 2002;346: 1773-1780.
9. Vermeres P and Agostoni P. Should degenerated saphenous vein grafts routinely be sealed with drug-eluting stents? J Interv Cardiol. 2005;18:467-73.
10. Ge L, Iakovou I, Sangiorgi GM, Chieffo A, Melzi G, Cosgrave J, Montorfano M, Michev I, Airoldi F, Carlino M, Corvaja N, Colombo A. Treatment of saphenous vein graft lesions with drug eluting stents. J Am Coll Cardiol 2005;45: 989-994.
11. Hoye A, Lemos PA, Arampatzis CA, Saia F, Tanabe K, Degertekin M, Hofma S, McFadden E, Sianos G, Smits PC, van der Giessen WJ, de Feyter P, van Domburg RT, Serruys PW. Effectiveness of the sirolimus-eluting stent in the treatment of saphenous vein graft disease. J Invasive Cardiol 2004;16: 230-233.
12. Price MJ, Sawhney N, Kao JA, Madrid A, Schatz RA, Teirstein PS. Clinical outcomes after sirolimus-eluting stent implantation for de novo saphenous vein graft lesions. Catheter Cardiovasc Interv 2005;65: 208-211.
13. Lee MS, Shah AP, Aragon J, Jamali A, Dohad S, Kar S, Makkar RR. Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts. Catheter Cardiovasc Interv. 2005;66:507-11.
14. Chu WW, Rha SW, Kuchulakanti PK, Cheneau E, Torguson R, Pinnow E, Alexieva-Fournadjiev J, Pichard AD, Satler LF, Kent KM, Lindsay J, Waksman R. Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention. Am J Cardiol. 2006;97:34-7.
15. Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Van den Branden F, Van Langenhove G. DELAYED RRISC (Death and Events at Long-term follow-up AnalYsis: Extended Duration of the Reduction of Restenosis In Saphenous vein grafts with Cypher stent) Investigators., Increased late mortality after sirolimus-eluting stents versus bare metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC trial. J Am Coll Cardiol 2007:50:261-267.
16. van Beusekom HM, van der Giessen WJ, van Suylen R, Bos E, Bosman FT, Serruys PW. Histology after stenting of human saphenous vein bypass graft: observation from surgically excised grafts 3 to 320 days after stent implantation. J Am Coll Cardiol 1993;21:45-54.
17. Douglas JS Jr. Percutaneous intervention in patients with prior coronary bypass surgery. In: Topol, editor, Textbook of interventional cardiology, 4th ed. Philadelphia: W.B. Saunders; 2003. P 317-344.
18. Depre C, Havaux X, Wijns W. Pathology of restenosis in saphenous bypass grafts after long-term stent implantation. Am J Clin Pathol. 1998; 110:378-84.
19. Ribichini F, Pugno F, Ferrero V, Wijns W, Vacca G, Vassanelli C, Virmani R. Long-term histological and immunohistochemical findings in human venous aorto-coronary bypass grafts. Clin Sci (Lond). 2008;114:211-20.
20. Mauri L, Hsieh WH, Massaro JM, Ho KK, D’Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356:1020-9.
21. Zahn R, Hamm C, Schneider S, Zeymer U, Nienaber CA, Richardt G, Kelm M, Levenson B, Bonzel T, Tebbe U, Sabin G, Senges J; German Cypher Stent Registry. Incidence and predictors of target vessel revascularization and clinical events rates of the sirolimus-eluting coronary stent (results from the prospective multicenter German Cypher stent registry). Am J Cardiol 2005;95: 1302-1308.
22. Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Bruining N, Van den Branden F, Van Langenhove G. Randomized Double-Blind Comparison of Sirolimus-Eluting Stent Versus Bare-Metal Stent Implantation in Diseased Saphenous Vein Grafts: Six-Month Angiographic, Intravascular Ultrasound, and Clinical Follow-Up of the RRISC Trial. J Am Coll Cardiol. 2006;48:2423-31.
23. Steg PG, Lopez-Sendon J, Lopez de Sa E, Goodman SG, Gore JM, Anderson FA Jr, Himbert D, Allegrone J, Van de Werf F; GRACE Investigators. External validity of clinical trials in acute myocardial infarction. Arch Intern Med 2007; 167:68-73.
24. Iakovou I, Stankovic G, Montorfano M, Airoldi F, Chieffo A, Sangiorgi GM, Carlino M, Corvaja N, Iassen M, Rogacka R, Vitrella G, Colombo A. Is overdilatation of 3.0 mm sirolimus-eluting stent associated with a higher restenosis rate? Catheter Cardiovasc Interv. 2005;64:129-33.
25. Grines CL, Bonow RO, Casey DE Jr, Gardner TJ, Lockhart PB, Moliterno DJ, O’Gara P, Whitlow P; American Heart Association; American College of Cardiology; Society for Cardiovascular Angiography and Interventions; American College of Surgeons; American Dental Association; American College of Physicians. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol. 2007;49:734-9.